Get jobo
Healthcare

Engage Bio

Potent, durable, and redosable non-viral genetic medicines

YC-W22Healthcare -> TherapeuticsEarly
Website

What Engage Bio does

Engage Bio has developed Tethosomes, a new class of non-viral DNA which finally unleashes potent, durable, redosable, and scalable genetic medicine. In 2026 Engage was acquired by Eli Lilly.

No open roles recorded right now.

That does not mean they are not hiring — plenty of roles never reach a job board. The careers page below is the earliest place a new opening appears.

Check the company’s own careers page — linked at the top — before a job board. A role appears there first, sometimes weeks before it is syndicated anywhere else.

Questions and experiences

Nobody has asked anything about Engage Bio yet. If you have interviewed here, what you know is worth more to the next person than anything on the rest of this page.

Reviewed before it appears. Do not include anything that identifies you or anyone else.

Company facts compiled from public sources and last refreshed 9 September 2026. Details change; treat the company’s own site as the authority.

jobo is a browser extension. Open this on a computer to install it.